Evidence map›Paper›PMID 8637868›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1996

Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment.

J Lu, Q Li, H Xie, Z J Chen, A E Borovitskaya, N K Maclaren, A L Notkins, M S Lan

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Birth and coming of age of islet autoantibodies.Clinical and experimental immunology · 2019
    Review
  13. Article
  14. Regulation of CD4Frontiers in immunology · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. X-ray structure of the mature ectodomain of phogrin.Journal of structural and functional genomics · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

J LuLaboratory of Oral Medicine, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892-4322, USA.
Q Li
H Xie
Z J Chen
A E Borovitskaya
N K Maclaren
A L Notkins
M S Lan

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel cDNA, IA-2beta, was isolated from a mouse neonatal brain library. The predicted protein sequence revealed an extracellular domain, a transmembrane region, and an intracellular domain. The intracellular domain is 376 amino acids long and 74% identical to the intracellular domain of IA-2, a major autoantigen in insulin-dependent diabetes mellitus (IDDM). A partial sequence of the extracellular domain of IA-2beta indicates that it differs substantially (only 26% identical) from that of IA-2. Both molecules are expressed in islets and brain tissue. Forty-six percent (23 of 50) of the IDDM sera but none of the sera from normal controls (0 of 50) immunoprecipitated the intracellular domain of IA-2beta. Competitive inhibition experiments showed that IDDM sera have autoantibodies that recognize both common and distinct determinants on IA-2 and IA-2beta. Many IDDM sera are known to immunoprecipitate 37-kDa and 40-kDa tryptic fragments from islet cells, but the identity of the precursor protein(s) has remained elusive. The current study shows that treatment of recombinant IA-2beta and IA-2 with trypsin yields a 37-kDa fragment and a 40-kDa fragment, respectively, and that these fragments can be immunoprecipitated with diabetic sera. Absorption of diabetic sera with unlabeled recombinant IA-2 or IA-2beta, prior to incubation with radiolabeled 37-kDa and 40-kDa tryptic fragments derived from insulinoma or glucagonoma cells, blocks the immunoprecipitation of both of these radiolabeled tryptic fragments. We conclude that IA-2beta and IA-2 are the precursors of the 37-kDa and 40-kDa islet cell autoantigens, respectively, and that both IA-2 and IA-2beta are major autoantigens in IDDM.

Indexed as

Membrane ProteinsAmino Acid SequenceAnimalsAutoantigensBase SequenceCloning, MolecularCross ReactionsDiabetes Mellitus, Type 1Gene ExpressionIslets of LangerhansMembrane GlycoproteinsMiceMolecular Sequence DataPeptide FragmentsProtein Tyrosine Phosphatase, Non-Receptor Type 1Protein Tyrosine PhosphatasesAutoantigensMembrane GlycoproteinsMembrane ProteinsPeptide FragmentsProtein Tyrosine Phosphatase, Non-Receptor Type 1Protein Tyrosine PhosphatasesPTPRN2 protein, humanPTPRN protein, humanPtprn protein, mouseReceptor-Like Protein Tyrosine Phosphatases, Class 8RNA, Messenger

Identifiers

PMID8637868
PMCPMC39791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.